Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 100

1.

A model-based estimation of inter-prefectural migration of physicians within Japan and associated factors: A 20-year retrospective study.

Okada N, Tanimoto T, Morita T, Higuchi A, Yoshida I, Kosugi K, Maeda Y, Nishikawa Y, Ozaki A, Tsuda K, Mori J, Ohnishi M, Ward LW, Narimatsu H, Yuji K, Kami M.

Medicine (Baltimore). 2018 Jun;97(22):e10878. doi: 10.1097/MD.0000000000010878.

2.

GWAS identifies two novel colorectal cancer loci at 16q24.1 and 20q13.12.

Tanikawa C, Kamatani Y, Takahashi A, Momozawa Y, Leveque K, Nagayama S, Mimori K, Mori M, Ishii H, Inazawa J, Yasuda J, Tsuboi A, Shimizu A, Sasaki M, Yamaji T, Sawada N, Iwasaki M, Tsugane S, Naito M, Wakai K, Koyama T, Takezaki T, Yuji K, Murakami Y, Nakamura Y, Kubo M, Matsuda K.

Carcinogenesis. 2018 May 3;39(5):652-660. doi: 10.1093/carcin/bgy026.

PMID:
29471430
3.

EGFR-TKI-Associated Interstitial Pneumonitis in Nivolumab-Treated Patients With Non-Small Cell Lung Cancer.

Oshima Y, Tanimoto T, Yuji K, Tojo A.

JAMA Oncol. 2018 Jan 11. doi: 10.1001/jamaoncol.2017.4526. [Epub ahead of print]

PMID:
29327061
4.

Organophosphate Poisoning and Terrorism.

Tanimoto T, Oshima Y, Yuji K, Ozaki A, Kami M.

Malays J Med Sci. 2017 Aug;24(4):111-112. doi: 10.21315/mjms2017.24.4.14. Epub 2017 Aug 18. No abstract available.

5.

Association between GvHD and nivolumab in the FDA adverse event reporting system.

Oshima Y, Tanimoto T, Yuji K, Tojo A.

Bone Marrow Transplant. 2017 Oct;52(10):1463-1464. doi: 10.1038/bmt.2017.158. Epub 2017 Jul 31. No abstract available.

PMID:
28759026
6.

Therapy-related Acute Myeloid Leukemia after the Long-term Administration of Low-dose Etoposide for Chronic-type Adult T-cell Leukemia-lymphoma: A Case Report and Literature Review.

Shimada N, Ohno N, Tanosaki R, Fuji S, Suzuki Y, Yuji K, Uchimaru K, Tojo A.

Intern Med. 2017;56(14):1879-1884. doi: 10.2169/internalmedicine.56.7763. Epub 2017 Jul 15.

7.

Association Between Aortic Dissection and Systemic Exposure of Vascular Endothelial Growth Factor Pathway Inhibitors in the Japanese Adverse Drug Event Report Database.

Oshima Y, Tanimoto T, Yuji K, Tojo A.

Circulation. 2017 Feb 21;135(8):815-817. doi: 10.1161/CIRCULATIONAHA.116.025144. No abstract available.

8.

Overview of BioBank Japan follow-up data in 32 diseases.

Hirata M, Nagai A, Kamatani Y, Ninomiya T, Tamakoshi A, Yamagata Z, Kubo M, Muto K, Kiyohara Y, Mushiroda T, Murakami Y, Yuji K, Furukawa Y, Zembutsu H, Tanaka T, Ohnishi Y, Nakamura Y; BioBank Japan Cooperative Hospital Group, Matsuda K.

J Epidemiol. 2017 Mar;27(3S):S22-S28. doi: 10.1016/j.je.2016.12.006. Epub 2017 Feb 10. Review.

9.

Cross-sectional analysis of BioBank Japan clinical data: A large cohort of 200,000 patients with 47 common diseases.

Hirata M, Kamatani Y, Nagai A, Kiyohara Y, Ninomiya T, Tamakoshi A, Yamagata Z, Kubo M, Muto K, Mushiroda T, Murakami Y, Yuji K, Furukawa Y, Zembutsu H, Tanaka T, Ohnishi Y, Nakamura Y; BioBank Japan Cooperative Hospital Group, Matsuda K.

J Epidemiol. 2017 Mar;27(3S):S9-S21. doi: 10.1016/j.je.2016.12.003. Epub 2017 Feb 9.

10.

Overview of the BioBank Japan Project: Study design and profile.

Nagai A, Hirata M, Kamatani Y, Muto K, Matsuda K, Kiyohara Y, Ninomiya T, Tamakoshi A, Yamagata Z, Mushiroda T, Murakami Y, Yuji K, Furukawa Y, Zembutsu H, Tanaka T, Ohnishi Y, Nakamura Y; BioBank Japan Cooperative Hospital Group, Kubo M.

J Epidemiol. 2017 Mar;27(3S):S2-S8. doi: 10.1016/j.je.2016.12.005. Epub 2017 Feb 8. Review.

11.

"Imatinib-induced gastric antral vascular ectasia" in a reporting system of the Japanese Adverse Drug Event Report database.

Oshima Y, Yuji K, Tojo A.

Int J Hematol. 2016 May;103(5):596-8. doi: 10.1007/s12185-016-1980-8. Epub 2016 Mar 15. No abstract available.

PMID:
26980219
12.

Compensation programs after withdrawal of the recommendation for HPV vaccine in Japan.

Yuji K, Nakada H.

Hum Vaccin Immunother. 2016 May 3;12(5):1321-4. doi: 10.1080/21645515.2015.1107686. Epub 2015 Oct 29.

13.

Treatment of chronic lymphocytic leukemia with bendamustine in an HIV-infected patient on antiretroviral therapy: a case report and review of the literature.

Shimada N, Yuji K, Ohno N, Koibuchi T, Oyaizu N, Uchimaru K, Tojo A.

Clin Case Rep. 2015 Jun;3(6):453-60. doi: 10.1002/ccr3.244. Epub 2015 Apr 22.

14.

How do medical journalists treat cancer-related issues?

Nakada H, Tsubokura M, Kishi Y, Yuji K, Matsumura T, Kami M.

Ecancermedicalscience. 2015 Jan 26;9:502. doi: 10.3332/ecancer.2015.502. eCollection 2015.

15.

Advanced human T-cell leukemia virus type 1 carriers and early-stage indolent adult T-cell leukemia-lymphoma are indistinguishable based on CADM1 positivity in flow cytometry.

Kobayashi S, Watanabe E, Ishigaki T, Ohno N, Yuji K, Nakano K, Yamochi T, Watanabe N, Tojo A, Watanabe T, Uchimaru K.

Cancer Sci. 2015 May;106(5):598-603. doi: 10.1111/cas.12639. Epub 2015 Mar 20.

16.

A case of post-transplant adult T-cell leukemia/lymphoma presenting myelopathy similar to but distinct from human T-cell leukemia virus type I (HTLV- I)-associated myelopathy.

Kawamata T, Ohno N, Sato K, Kobayashi M, Jo N, Yuji K, Tanosaki R, Yamano Y, Tojo A, Uchimaru K.

Springerplus. 2014 Oct 4;3:581. doi: 10.1186/2193-1801-3-581. eCollection 2014.

17.

Clearance of blasts from peripheral blood during induction chemotherapy using exponential decay model predicts complete remission and long-term survival in adult acute myeloid leukemia.

Konuma T, Kato S, Yuji K, Ohno N, Uchimaru K, Takahashi S, Tojo A.

Int J Lab Hematol. 2015 Jun;37(3):e59-62. doi: 10.1111/ijlh.12302. Epub 2014 Oct 12. No abstract available.

PMID:
25308202
18.

23andMe and the FDA.

Yuji K, Tanimoto T, Oshima Y.

N Engl J Med. 2014 Jun 5;370(23):2248. doi: 10.1056/NEJMc1404692. No abstract available.

PMID:
24897101
19.

Development of a national agreement on human papillomavirus vaccination in Japan: an infodemiology study.

Nakada H, Yuji K, Tsubokura M, Ohsawa Y, Kami M.

J Med Internet Res. 2014 May 15;16(5):e129. doi: 10.2196/jmir.2846.

20.

CADM1 expression and stepwise downregulation of CD7 are closely associated with clonal expansion of HTLV-I-infected cells in adult T-cell leukemia/lymphoma.

Kobayashi S, Nakano K, Watanabe E, Ishigaki T, Ohno N, Yuji K, Oyaizu N, Asanuma S, Yamagishi M, Yamochi T, Watanabe N, Tojo A, Watanabe T, Uchimaru K.

Clin Cancer Res. 2014 Jun 1;20(11):2851-61. doi: 10.1158/1078-0432.CCR-13-3169. Epub 2014 Apr 11.

21.

Impact of sex incompatibility on the outcome of single-unit cord blood transplantation for adult patients with hematological malignancies.

Konuma T, Kato S, Ooi J, Oiwa-Monna M, Ebihara Y, Mochizuki S, Yuji K, Ohno N, Kawamata T, Jo N, Yokoyama K, Uchimaru K, Tojo A, Takahashi S.

Bone Marrow Transplant. 2014 May;49(5):634-9. doi: 10.1038/bmt.2014.10. Epub 2014 Feb 17.

PMID:
24535130
22.

Effect of ABO blood group incompatibility on the outcome of single-unit cord blood transplantation after myeloablative conditioning.

Konuma T, Kato S, Ooi J, Oiwa-Monna M, Ebihara Y, Mochizuki S, Yuji K, Ohno N, Kawamata T, Jo N, Yokoyama K, Uchimaru K, Tojo A, Takahashi S.

Biol Blood Marrow Transplant. 2014 Apr;20(4):577-81. doi: 10.1016/j.bbmt.2013.12.563. Epub 2013 Dec 22.

23.

Single-unit cord blood transplantation after granulocyte colony-stimulating factor-combined myeloablative conditioning for myeloid malignancies not in remission.

Konuma T, Kato S, Ooi J, Oiwa-Monna M, Ebihara Y, Mochizuki S, Yuji K, Ohno N, Kawamata T, Jo N, Yokoyama K, Uchimaru K, Asano S, Tojo A, Takahashi S.

Biol Blood Marrow Transplant. 2014 Mar;20(3):396-401. doi: 10.1016/j.bbmt.2013.12.555. Epub 2013 Dec 11.

24.

Association between acute myelogenous leukemia and thrombopoietin receptor agonists in patients with immune thrombocytopenia.

Oshima Y, Yuji K, Tanimoto T, Hinomura Y, Tojo A.

Intern Med. 2013;52(19):2193-201. Epub 2012 Mar 1.

25.

Loss of CCR4 antigen expression after mogamulizumab therapy in a case of adult T-cell leukaemia-lymphoma.

Ohno N, Kobayashi S, Ishigaki T, Yuji K, Kobayashi M, Sato K, Watanabe N, Tojo A, Uchimaru K.

Br J Haematol. 2013 Dec;163(5):683-5. doi: 10.1111/bjh.12555. Epub 2013 Sep 3. No abstract available.

PMID:
23998261
26.

Development of peripheral T-cell lymphoma not otherwise specified in an HTLV-1 carrier.

Ishigaki T, Isobe M, Kobayashi S, Yuji K, Ohno N, Watanabe N, Tojo A, Uchimaru K.

Int J Hematol. 2013 May;97(5):667-72. doi: 10.1007/s12185-013-1314-z. Epub 2013 Apr 9. Review.

PMID:
23568283
27.

Does Twitter trigger bursts in signature collections?

Yamaguchi R, Imoto S, Kami M, Watanabe K, Miyano S, Yuji K.

PLoS One. 2013;8(3):e58252. doi: 10.1371/journal.pone.0058252. Epub 2013 Mar 6.

28.

Effect of dietary blueberry (Vaccinium ashei Reade) leaves on serum and hepatic lipid levels in rats.

Yuji K, Sakaida H, Kai T, Fukuda N, Yukizaki C, Sakai M, Tsubouchi H, Kataoka H.

J Oleo Sci. 2013;62(2):89-96.

29.

The CD3 versus CD7 plot in multicolor flow cytometry reflects progression of disease stage in patients infected with HTLV-I.

Kobayashi S, Tian Y, Ohno N, Yuji K, Ishigaki T, Isobe M, Tsuda M, Oyaizu N, Watanabe E, Watanabe N, Tani K, Tojo A, Uchimaru K.

PLoS One. 2013;8(1):e53728. doi: 10.1371/journal.pone.0053728. Epub 2013 Jan 22.

30.

Forecasting Japan's physician shortage in 2035 as the first full-fledged aged society.

Yuji K, Imoto S, Yamaguchi R, Matsumura T, Murashige N, Kodama Y, Minayo S, Imai K, Kami M.

PLoS One. 2012;7(11):e50410. doi: 10.1371/journal.pone.0050410. Epub 2012 Nov 30.

31.

Eltrombopag in refractory aplastic anemia.

Oshima Y, Yuji K, Tojo A.

N Engl J Med. 2012 Sep 20;367(12):1162; author reply 1163. doi: 10.1056/NEJMc1209254. No abstract available.

PMID:
22992084
32.

Acute lymphoblastic leukemia with t(1;19)(q23;p13)/TCF3-PBX1 fusion in an adult male with Down Syndrome.

Yamamoto S, Ebihara Y, Mochizuki S, Tsuda M, Yuji K, Uchimaru K, Tojo A, Tsuji K.

Acta Haematol. 2012;128(4):242-3. doi: 10.1159/000340049. Epub 2012 Aug 31. No abstract available.

PMID:
22948124
33.

Effect of renal impairment on the pharmacokinetics of memantine.

Moritoyo T, Hasunuma T, Harada K, Tateishi T, Watanabe M, Kotegawa T, Nagai M, Kumagai Y, Fujitani T, Okura T, Fukuoka T, Miyoshi K, Matsuura B, Furukawa S, Kobori T, Moritoyo H, Nishikawa N, Tsujii T, Iwaki H, Nakamura M, Makino S, Ohnuma K, Yuji K, Hashimoto M, Takasu M, Hashizume Y, You K, Matsumura T, Tanaka Y, Matsumoto N, Nakamura J, Miura J, Akizawa T, Kitazawa K, Shibata T, Kuroki A, Honda H, Mukai M, Ohashi K, Morimoto T, Imai H, Okudaira T, Sato F, Imanaga J, Tanaka K, Nomoto M.

J Pharmacol Sci. 2012;119(4):324-9. Epub 2012 Jul 21.

34.

The long and winding road for the Fukushima nuclear workers.

Tanimoto T, Yuji K, Kodama Y, Matsumura T, Yamamoto H, Mori J, Hosoda M, Uchida N, Kami M, Taniguchi S; Taniguchi Project.

Lancet. 2012 Mar 10;379(9819):e34. doi: 10.1016/S0140-6736(12)60394-8. No abstract available.

PMID:
22405801
35.

Allogeneic cord blood transplantation for adult acute lymphoblastic leukemia: retrospective survey involving 256 patients in Japan.

Matsumura T, Kami M, Yamaguchi T, Yuji K, Kusumi E, Taniguchi S, Takahashi S, Okada M, Sakamaki H, Azuma H, Takanashi M, Kodo H, Kai S, Inoue-Nagamura T, Kato K, Kato S; Japan Cord Blood Bank Network.

Leukemia. 2012 Jul;26(7):1482-6. doi: 10.1038/leu.2012.11. Epub 2012 Jan 17.

PMID:
22290068
36.

Age, gender, will, and use of home-visit nursing care are critical factors in home care for malignant diseases; a retrospective study involving 346 patients in Japan.

Kodama Y, Matsumura T, Yamaguchi T, Takita M, Kawagoe S, Kimura Y, Hirahara S, Suzuki H, Ohta H, Onozawa S, Wada T, Nakamura Y, Nakano K, Kami M, Yuji K.

BMC Palliat Care. 2011 Nov 1;10:17. doi: 10.1186/1472-684X-10-17.

37.

Internet-based survey on medical manga in Japan.

Kishi Y, Matsumura T, Murishige N, Kodama Y, Hatanaka N, Takita M, Sakamoto K, Hamaki T, Kusumi E, Kobayashi K, Yuji K, Narimatsu H, Kami M.

Health Commun. 2011 Oct;26(7):676-8. doi: 10.1080/10410236.2011.563352. Epub 2011 Jun 9.

PMID:
21660790
38.

Sharing information on adverse events.

Yuji K, Narimatsu H, Tanimoto T, Komatsu T, Kami M.

Lancet. 2011 May 14;377(9778):1654. doi: 10.1016/S0140-6736(11)60676-4. No abstract available.

PMID:
21571148
39.

Police investigation into multidrug-resistant acinetobacter baumannii outbreak in Japan.

Yuji K, Oiso G, Matsumura T, Murashige N, Kami M.

Clin Infect Dis. 2011 Feb 1;52(3):422. doi: 10.1093/cid/ciq081. No abstract available.

PMID:
21217192
40.

Japan's health policy.

Yuji K, Matsumura T, Kodama Y, Murashige N, Kami M.

Lancet. 2010 Dec 4;376(9756):1900. doi: 10.1016/S0140-6736(10)62213-1. No abstract available.

PMID:
21130286
41.

Human papillomavirus vaccine coverage.

Yuji K, Matsumura T, Miyano S, Tsuchiya R, Kami M.

Lancet. 2010 Jul 31;376(9738):329-30; author reply 330. doi: 10.1016/S0140-6736(10)61180-4. No abstract available.

PMID:
20674715
42.

The usefulness of pathogen inactivation during an outbreak of the new strain of influenza (H1N1).

Narimatsu H, Yuji K, Shimodaira S, Kami M.

Transfus Med Rev. 2010 Apr;24(2):151-2. doi: 10.1016/j.tmrv.2009.12.001. No abstract available.

PMID:
20303039
43.

Structural problems of medical news reports in newspapers: a verification of news reports on an incident of mass nosocomial Serratia infection.

Mizuno Y, Narimatsu H, Kishi Y, Kodama Y, Murashige N, Yuji K, Matsumura T, Kami M.

J Infect Chemother. 2010 Apr;16(2):107-12. doi: 10.1007/s10156-009-0013-4. Epub 2010 Jan 27.

PMID:
20108020
44.

Retrospective study on home care for patients with hematologic malignancies.

Kodama Y, Takita M, Kawagoe S, Hirahara S, Kimura Y, Onozawa S, Wada T, Nakano K, Kami M, Matsumura T, Yuji K.

Jpn J Clin Oncol. 2009 Sep;39(9):606-11. doi: 10.1093/jjco/hyp064. Epub 2009 Jun 17.

PMID:
19535385
45.

Possible involvement of RasGRP4 in leukemogenesis.

Watanabe-Okochi N, Oki T, Komeno Y, Kato N, Yuji K, Ono R, Harada Y, Harada H, Hayashi Y, Nakajima H, Nosaka T, Kitaura J, Kitamura T.

Int J Hematol. 2009 May;89(4):470-481. doi: 10.1007/s12185-009-0299-0. Epub 2009 Apr 7.

PMID:
19350351
46.

Study of newspaper reports regarding clinical trials in Japan.

Takita M, Narimatsu H, Tomoko M, Kishi Y, Murashige N, Hamaki T, Kodama Y, Yuji K, Tanaka Y, Kami M.

J Clin Oncol. 2009 Apr 20;27(12):2099-101. doi: 10.1200/JCO.2008.21.3967. Epub 2009 Mar 16. No abstract available.

PMID:
19289609
47.

Trends in cancer coverage in Japanese newspapers.

Kishi Y, Nagamatsu S, Takita M, Kodama Y, Hori A, Hatanaka N, Hamaki T, Kusumi E, Kobayashi K, Matsumura T, Yuji K, Narimatsu H, Tanaka Y, Kami M.

J Clin Oncol. 2008 Dec 20;26(36):6017-20. doi: 10.1200/JCO.2008.20.1392. Epub 2008 Nov 24. No abstract available.

PMID:
19029407
48.

Cooperative relationship between pharmaceutical companies, academia, and media explains sharp decrease in frequency of pulmonary complications after bortezomib in Japan.

Narimatsu H, Hori A, Matsumura T, Kodama Y, Takita M, Kishi Y, Hamaki T, Yuji K, Tanaka Y, Komatsu T, Kami M.

J Clin Oncol. 2008 Dec 10;26(35):5820-3. doi: 10.1200/JCO.2008.20.3307. Epub 2008 Nov 10. No abstract available.

PMID:
19001340
49.

Detailed analysis of visitors to cancer-related web sites.

Narimatsu H, Matsumura T, Morita T, Kishi Y, Yuji K, Kami M, Komatsu T, Tanaka Y, Sawa T, Nakata Y.

J Clin Oncol. 2008 Sep 1;26(25):4219-23. doi: 10.1200/JCO.2008.18.7468. No abstract available.

PMID:
18757342
50.

Current status of the Japanese cancer registry system: results of a nationwide survey.

Sawa T, Yuji K, Kami M, Ohno-Machado L, Nakata Y.

AMIA Annu Symp Proc. 2007 Oct 11:1104.

PMID:
18694201

Supplemental Content

Support Center